Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Deleting adipose FXR exacerbates metabolic defects and induces endocannabinoid lipid, 2-oleoyl glycerol, in obesity.
Journal: Journal of lipid research
Published: October 04, 2024
Small heterodimer partner deletion prevents hepatic steatosis and when combined with farnesoid X receptor loss protects against type 2 diabetes in mice.
Journal: Hepatology (Baltimore, Md.)
Published: December 20, 2016
Showing 1-2 of 2
Last Updated: 09/26/2026